Walter & Keenan Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.52M Buy
10,005
+12
+0.1% +$4.28K 0.99% 28
2025
Q4
$3.27M Buy
9,993
+13
+0.1% +$4.12K 0.88% 28
2025
Q3
$2.82M Sell
9,980
-131
-1% -$38K 0.78% 35
2025
Q2
$2.82M Buy
10,111
+181
+2% +$51.3K 0.82% 34
2025
Q1
$3.09M Buy
9,930
+93
+0.9% +$27.5K 0.93% 29
2024
Q4
$2.56M Sell
9,837
-23
-0.2% -$6.82K 0.77% 36
2024
Q3
$3.18M Buy
9,860
+3
+0% +$981 0.97% 29
2024
Q2
$3.08M Sell
9,857
-32
-0.3% -$9.4K 0.98% 29
2024
Q1
$2.81M Buy
9,889
+58
+0.6% +$17K 0.92% 35
2023
Q4
$2.83M Buy
9,831
+1
+0% +$272 1.01% 30
2023
Q3
$2.64M Hold
9,830
1.03% 30
2023
Q2
$2.18M Buy
9,830
+94
+1% +$21.8K 0.8% 38
2023
Q1
$2.35M Sell
9,736
-700
-7% -$172K 0.89% 38
2022
Q4
$2.74M Buy
10,436
+390
+4% +$105K 1.08% 31
2022
Q3
$2.26M Buy
10,046
+142
+1% +$34.4K 0.96% 37
2022
Q2
$2.41M Sell
9,904
-100
-1% -$24.5K 0.95% 35
2022
Q1
$2.42M Hold
10,004
0.82% 40
2021
Q4
$2.25M Buy
10,004
+351
+4% +$74.1K 0.73% 46
2021
Q3
$2.05M Buy
9,653
+184
+2% +$42.4K 0.7% 44
2021
Q2
$2.31M Sell
9,469
-100
-1% -$24.6K 0.8% 39
2021
Q1
$2.38M Sell
9,569
-1,787
-16% -$426K 0.84% 38
2020
Q4
$2.61M Buy
11,356
+65
+0.6% +$15K 0.94% 35
2020
Q3
$2.87M Sell
11,291
-50
-0.4% -$12.4K 1.14% 29
2020
Q2
$2.67M Sell
11,341
-17,752
-61% -$4.05M 1.08% 30
2020
Q1
$5.75M Buy
29,093
+18,652
+179% +$4.07M 2.28% 11
2019
Q4
$2.52M Sell
10,441
-3,873
-27% -$854K 0.97% 36
2019
Q3
$2.77M Buy
14,314
+3,764
+36% +$722K 1.05% 34
2019
Q2
$1.94M Buy
10,550
+350
+3% +$62.7K 0.86% 36
2019
Q1
$1.94M Buy
10,200
+455
+5% +$86.9K 0.85% 38
2018
Q4
$18.2M Buy
9,745
+1,150
+13% +$224K 8.19% 1
2018
Q3
$1.78K Sell
8,595
-500
-5% -$98.5K 0.53% 40
2018
Q2
$1.68M Buy
9,095
+155
+2% +$27.4K 0.72% 43
2018
Q1
$1.52M Buy
8,940
+345
+4% +$63.3K 0.66% 49
2017
Q4
$1.5M Buy
8,595
+110
+1% +$19.5K 0.63% 53
2017
Q3
$1.58M Buy
8,485
+485
+6% +$85.9K 0.73% 46
2017
Q2
$1.38M Buy
8,000
+1,400
+21% +$228K 0.69% 47
2017
Q1
$1.08M Buy
6,600
+3,400
+106% +$565K 0.56% 55
2016
Q4
$468K Buy
3,200
+600
+23% +$90.3K 0.25% 86
2016
Q3
$434K Sell
2,600
-1,000
-28% -$169K 0.24% 90
2016
Q2
$548K Buy
3,600
+1,200
+50% +$187K 0.31% 77
2016
Q1
$360K Buy
2,400
+300
+14% +$44.6K 0.21% 95
2015
Q4
$341K Hold
2,100
0.2% 97
2015
Q3
$290K Hold
2,100
0.18% 108
2015
Q2
$322K Hold
2,100
0.19% 106
2015
Q1
$336K Hold
2,100
0.19% 108
2014
Q4
$335K Sell
2,100
-100
-5% -$15.6K 0.19% 104
2014
Q3
$309K Hold
2,200
0.18% 111
2014
Q2
$260K Hold
2,200
0.14% 123
2014
Q1
$271K Buy
+2,200
New +$267K 0.15% 113

Other funds holding AMGN

Walter & Keenan Wealth Management's AMGN Position: Q1 2026 in Review

Walter & Keenan Wealth Management increased its Amgen (AMGN) stake by 0.12% in Q1 2026, buying an estimated $4.28K and bringing the position to 10,005 shares worth $3.52M. The position accounts for 0.99% of the portfolio, ranked #28.

Walter & Keenan Wealth Management first reported a position in AMGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $18.2M in Q4 2018. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Walter & Keenan Wealth Management held 10,005 shares of Amgen worth $3.52M as of Q1 2026.
  • Walter & Keenan Wealth Management bought 12 Amgen shares in Q1 2026, an estimated $4.28K.
  • Amgen made up 0.99% of Walter & Keenan Wealth Management's portfolio in Q1 2026, its #28 holding.
  • Walter & Keenan Wealth Management first reported a position in Amgen in Q1 2014 and has held it in 49 quarters since.
  • Walter & Keenan Wealth Management's Amgen position peaked at $18.2M in Q4 2018.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Walter & Keenan Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.